PDB Short entry for 2WNS HEADER TRANSFERASE 19-JUL-09 2WNS TITLE HUMAN OROTATE PHOSPHORIBOSYLTRANSFERASE (OPRTASE) DOMAIN OF TITLE 2 URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMPS) IN COMPLEX WITH TITLE 3 ITS SUBSTRATE OROTIDINE 5'-MONOPHOSPHATE (OMP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: OROTATE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: OPRTASE DOMAIN, RESIDUES 7-203; COMPND 5 SYNONYM: OPRTASE, URIDINE 5'-MONOPHOSPHATE SYNTHASE; COMPND 6 EC: 2.4.2.10; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) R3 PRARE; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PNIC-CH2 KEYWDS ALTERNATIVE SPLICING, MULTIFUNCTIONAL ENZYME, LYASE, KEYWDS 2 TRANSFERASE, POLYMORPHISM, DECARBOXYLASE, PHOSPHOPROTEIN, KEYWDS 3 DISEASE MUTATION, GLYCOSYLTRANSFERASE, PYRIMIDINE KEYWDS 4 BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR M.MOCHE,A.ROOS,C.H.ARROWSMITH,H.BERGLUND,C.BOUNTRA, AUTHOR 2 R.COLLINS,A.M.EDWARDS,S.FLODIN,A.FLORES,S.GRASLUND, AUTHOR 3 M.HAMMARSTROM,A.JOHANSSON,I.JOHANSSON,T.KARLBERG, AUTHOR 4 T.KOTYENOVA,A.KOTZCH,T.K.NIELSEN,T.NYMAN,C.PERSSON, AUTHOR 5 J.SAGEMARK,H.SCHUELER,P.SCHUTZ,M.I.SIPONEN,L.SVENSSON, AUTHOR 6 A.G.THORSELL,L.TRESAUGUES,S.VANDENBERG,J.WEIGELT,M.WELIN, AUTHOR 7 M.WISNIEWSKA,P.NORDLUND REVDAT 1 11-AUG-09 2WNS 0 JRNL AUTH M.MOCHE,A.ROOS,C.H.ARROWSMITH,H.BERGLUND,C.BOUNTRA, JRNL AUTH 2 R.COLLINS,A.M.EDWARDS,S.FLODIN,A.FLORES,S.GRASLUND, JRNL AUTH 3 M.HAMMARSTROM,A.JOHANSSON,I.JOHANSSON,T.KARLBERG, JRNL AUTH 4 T.KOTYENOVA,A.KOTZCH,T.K.NIELSEN,T.NYMAN,C.PERSSON, JRNL AUTH 5 J.SAGEMARK,H.SCHUELER,P.SCHUTZ,M.I.SIPONEN, JRNL AUTH 6 L.SVENSSON,A.G.THORSELL,L.TRESAUGUES,S.VANDENBERG, JRNL AUTH 7 J.WEIGELT,M.WELIN,M.WISNIEWSKA,P.NORDLUND JRNL TITL HUMAN OROTATE PHOSPHORIBOSYLTRANSFERASE (OPRTASE) JRNL TITL 2 DOMAIN OF URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMPS) JRNL TITL 3 IN COMPLEX WITH ITS SUBSTRATE OROTIDINE 5'- JRNL TITL 4 MONOPHOSPHATE (OMP) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 100.00 REMARK 3 NUMBER OF REFLECTIONS : 26940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.18244 REMARK 3 R VALUE (WORKING SET) : 0.18003 REMARK 3 FREE R VALUE : 0.22791 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1418 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.900 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.949 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1959 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.248 REMARK 3 BIN FREE R VALUE SET COUNT : 103 REMARK 3 BIN FREE R VALUE : 0.243 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3060 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.1 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.510 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.00 REMARK 3 B22 (A**2) : -1.09 REMARK 3 B33 (A**2) : 3.31 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 1.54 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.173 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.155 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.114 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.909 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3149 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2123 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4271 ; 1.437 ; 2.011 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5239 ; 1.181 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 398 ; 5.007 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 122 ;37.822 ;24.508 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 584 ;14.229 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;19.401 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 524 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3408 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 571 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1970 ; 0.697 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 811 ; 0.189 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3208 ; 1.291 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1179 ; 2.195 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1062 ; 3.678 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2WNS COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUL-09 REMARK 100 THE PDBE ID CODE IS EBI-40401 REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28358 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.90 REMARK 200 RESOLUTION RANGE LOW (A) : 37.06 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.0 REMARK 200 R MERGE (I) : 0.09 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.80 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.0 REMARK 200 R MERGE FOR SHELL (I) : 0.57 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2ZYK REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.80000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.78 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 6 REMARK 465 ALA A 204 REMARK 465 HIS A 205 REMARK 465 HIS A 206 REMARK 465 HIS A 207 REMARK 465 HIS A 208 REMARK 465 HIS A 209 REMARK 465 HIS A 210 REMARK 465 MET B 6 REMARK 465 ALA B 7 REMARK 465 HIS B 207 REMARK 465 HIS B 208 REMARK 465 HIS B 209 REMARK 465 HIS B 210 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 187 CG CD CE NZ REMARK 470 HIS B 205 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 101 -123.61 39.98 REMARK 500 THR A 127 -85.01 -112.32 REMARK 500 SER B 30 8.06 -69.20 REMARK 500 GLU B 99 -145.88 -136.97 REMARK 500 LYS B 106 -165.31 -107.00 REMARK 500 THR B 127 -91.01 -108.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 600 REMARK 600 HETEROGEN REMARK 600 OROTIDINE-5'-MONOPHOSPHATE (OMP): THE OROTIDINE REMARK 600 5-MONOPHOSPHATE, OMP, WAS RENAMED INTO DRG SINCE THERE WAS REMARK 600 A PROBLEM WITH THE REFMAC5 OMP DEFAULT DICTIONARY REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OMP A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OMP B 550 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1208 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JGY RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN OROTIDINE-5 REMARK 900 '-DECARBOXYLASE DOMAIN OF HUMAN URIDINE REMARK 900 MONOPHOSPHATE SYNTHETASE (UMPS) REMARK 900 RELATED ID: 2V30 RELATED DB: PDB REMARK 900 HUMAN OROTIDINE 5'-PHOSPHATE DECARBOXYLASE REMARK 900 DOMAIN OF URIDINE MONOPHOSPATE SYNTHETASE ( REMARK 900 UMPS) IN COMPLEX WITH ITS PRODUCT UMP. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE CONTAINS ONLY THE OROTATE REMARK 999 PHOSPHORIBOSYLTRANSFERASE DOMAIN OF UMPS AND IS FURTHER REMARK 999 CUT BY SIX AA IN THE N-TERMINUS AND IN ADDITION CONTAINS REMARK 999 AN C-TERMINAL HEXAHISTIDINE TAG. DBREF 2WNS A 6 6 PDB 2WNS 2WNS 6 6 DBREF 2WNS A 7 203 UNP P11172 PYR5_HUMAN 7 203 DBREF 2WNS A 204 210 PDB 2WNS 2WNS 204 210 DBREF 2WNS B 6 6 PDB 2WNS 2WNS 6 6 DBREF 2WNS B 7 203 UNP P11172 PYR5_HUMAN 7 203 DBREF 2WNS B 204 210 PDB 2WNS 2WNS 204 210 SEQRES 1 A 205 MET ALA LEU GLY PRO LEU VAL THR GLY LEU TYR ASP VAL SEQRES 2 A 205 GLN ALA PHE LYS PHE GLY ASP PHE VAL LEU LYS SER GLY SEQRES 3 A 205 LEU SER SER PRO ILE TYR ILE ASP LEU ARG GLY ILE VAL SEQRES 4 A 205 SER ARG PRO ARG LEU LEU SER GLN VAL ALA ASP ILE LEU SEQRES 5 A 205 PHE GLN THR ALA GLN ASN ALA GLY ILE SER PHE ASP THR SEQRES 6 A 205 VAL CYS GLY VAL PRO TYR THR ALA LEU PRO LEU ALA THR SEQRES 7 A 205 VAL ILE CYS SER THR ASN GLN ILE PRO MET LEU ILE ARG SEQRES 8 A 205 ARG LYS GLU THR LYS ASP TYR GLY THR LYS ARG LEU VAL SEQRES 9 A 205 GLU GLY THR ILE ASN PRO GLY GLU THR CYS LEU ILE ILE SEQRES 10 A 205 GLU ASP VAL VAL THR SER GLY SER SER VAL LEU GLU THR SEQRES 11 A 205 VAL GLU VAL LEU GLN LYS GLU GLY LEU LYS VAL THR ASP SEQRES 12 A 205 ALA ILE VAL LEU LEU ASP ARG GLU GLN GLY GLY LYS ASP SEQRES 13 A 205 LYS LEU GLN ALA HIS GLY ILE ARG LEU HIS SER VAL CYS SEQRES 14 A 205 THR LEU SER LYS MET LEU GLU ILE LEU GLU GLN GLN LYS SEQRES 15 A 205 LYS VAL ASP ALA GLU THR VAL GLY ARG VAL LYS ARG PHE SEQRES 16 A 205 ILE GLN GLU ALA HIS HIS HIS HIS HIS HIS SEQRES 1 B 205 MET ALA LEU GLY PRO LEU VAL THR GLY LEU TYR ASP VAL SEQRES 2 B 205 GLN ALA PHE LYS PHE GLY ASP PHE VAL LEU LYS SER GLY SEQRES 3 B 205 LEU SER SER PRO ILE TYR ILE ASP LEU ARG GLY ILE VAL SEQRES 4 B 205 SER ARG PRO ARG LEU LEU SER GLN VAL ALA ASP ILE LEU SEQRES 5 B 205 PHE GLN THR ALA GLN ASN ALA GLY ILE SER PHE ASP THR SEQRES 6 B 205 VAL CYS GLY VAL PRO TYR THR ALA LEU PRO LEU ALA THR SEQRES 7 B 205 VAL ILE CYS SER THR ASN GLN ILE PRO MET LEU ILE ARG SEQRES 8 B 205 ARG LYS GLU THR LYS ASP TYR GLY THR LYS ARG LEU VAL SEQRES 9 B 205 GLU GLY THR ILE ASN PRO GLY GLU THR CYS LEU ILE ILE SEQRES 10 B 205 GLU ASP VAL VAL THR SER GLY SER SER VAL LEU GLU THR SEQRES 11 B 205 VAL GLU VAL LEU GLN LYS GLU GLY LEU LYS VAL THR ASP SEQRES 12 B 205 ALA ILE VAL LEU LEU ASP ARG GLU GLN GLY GLY LYS ASP SEQRES 13 B 205 LYS LEU GLN ALA HIS GLY ILE ARG LEU HIS SER VAL CYS SEQRES 14 B 205 THR LEU SER LYS MET LEU GLU ILE LEU GLU GLN GLN LYS SEQRES 15 B 205 LYS VAL ASP ALA GLU THR VAL GLY ARG VAL LYS ARG PHE SEQRES 16 B 205 ILE GLN GLU ALA HIS HIS HIS HIS HIS HIS HET OMP A 450 24 HET OMP B 550 24 HET CL B1208 1 HETNAM CL CHLORIDE ION HETNAM OMP OROTIDINE-5'-MONOPHOSPHATE FORMUL 3 CL CL 1- FORMUL 3 OMP 2(C10 H13 N2 O11 P) FORMUL 4 HOH *237(H2 O1) HELIX 1 1 LEU A 15 GLN A 19 5 5 HELIX 2 2 ARG A 46 ALA A 64 1 19 HELIX 3 3 ALA A 78 GLN A 90 1 13 HELIX 4 4 SER A 130 GLU A 142 1 13 HELIX 5 5 LYS A 160 ALA A 165 1 6 HELIX 6 6 LEU A 176 GLN A 186 1 11 HELIX 7 7 ARG A 196 GLU A 203 1 8 HELIX 8 8 ARG B 46 ALA B 64 1 19 HELIX 9 9 ALA B 78 GLN B 90 1 13 HELIX 10 10 SER B 130 GLU B 142 1 13 HELIX 11 11 LYS B 160 ALA B 165 1 6 HELIX 12 12 LEU B 176 GLN B 186 1 11 HELIX 13 13 ARG B 196 HIS B 205 1 10 SHEET 1 AA 2 PHE A 21 LYS A 22 0 SHEET 2 AA 2 TYR A 37 ILE A 38 -1 O TYR A 37 N LYS A 22 SHEET 1 AB 2 PHE A 26 VAL A 27 0 SHEET 2 AB 2 SER A 33 SER A 34 -1 O SER A 34 N PHE A 26 SHEET 1 AC 4 THR A 70 CYS A 72 0 SHEET 2 AC 4 CYS A 119 VAL A 126 1 O LEU A 120 N CYS A 72 SHEET 3 AC 4 ASP A 148 ASP A 154 1 O ASP A 148 N ILE A 121 SHEET 4 AC 4 ARG A 169 THR A 175 1 O ARG A 169 N ALA A 149 SHEET 1 AD 2 ILE A 95 ARG A 96 0 SHEET 2 AD 2 VAL A 109 GLU A 110 -1 O GLU A 110 N ILE A 95 SHEET 1 BA 2 PHE B 21 LYS B 22 0 SHEET 2 BA 2 TYR B 37 ILE B 38 -1 O TYR B 37 N LYS B 22 SHEET 1 BB 2 PHE B 26 VAL B 27 0 SHEET 2 BB 2 SER B 33 SER B 34 -1 O SER B 34 N PHE B 26 SHEET 1 BC 4 THR B 70 CYS B 72 0 SHEET 2 BC 4 CYS B 119 VAL B 126 1 O LEU B 120 N CYS B 72 SHEET 3 BC 4 ASP B 148 ASP B 154 1 O ASP B 148 N ILE B 121 SHEET 4 BC 4 ARG B 169 THR B 175 1 O ARG B 169 N ALA B 149 SHEET 1 BD 2 ILE B 95 ARG B 96 0 SHEET 2 BD 2 VAL B 109 GLU B 110 -1 O GLU B 110 N ILE B 95 CISPEP 1 PRO A 75 TYR A 76 0 0.33 CISPEP 2 PRO B 75 TYR B 76 0 1.18 SITE 1 AC1 19 LEU A 28 LYS A 29 TYR A 37 ILE A 38 SITE 2 AC1 19 GLU A 123 ASP A 124 VAL A 125 THR A 127 SITE 3 AC1 19 SER A 128 GLY A 129 SER A 130 SER A 131 SITE 4 AC1 19 ARG A 155 HOH A2134 HOH A2135 HOH A2137 SITE 5 AC1 19 HOH A2138 HOH A2139 HOH A2140 SITE 1 AC2 17 LEU B 28 LYS B 29 TYR B 37 ILE B 38 SITE 2 AC2 17 ASP B 124 VAL B 125 THR B 127 SER B 128 SITE 3 AC2 17 GLY B 129 SER B 131 ARG B 155 HOH B2002 SITE 4 AC2 17 HOH B2057 HOH B2059 HOH B2093 HOH B2094 SITE 5 AC2 17 HOH B2097 SITE 1 AC3 5 PRO A 80 THR A 83 PRO B 80 THR B 83 SITE 2 AC3 5 HOH B2006 CRYST1 64.400 43.600 71.000 90.00 113.40 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015528 0.000000 0.006720 0.00000 SCALE2 0.000000 0.022936 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015347 0.00000